Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

mTOR, translational control and human disease.

Andrew R Tee1, John Blenis

  • 1Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.

Seminars in Cell & Developmental Biology
|January 22, 2005
PubMed
Summary

Dysregulated mammalian target of rapamycin (mTOR) signaling disrupts cell growth and proliferation, leading to human diseases. Loss of tumor suppressors like TSC-1/2, PTEN, and LKB1 causes hamartoma syndromes due to heightened mTOR activity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ninth BHD International Symposium: Advancing research through global collaboration.

Cell stress & chaperones·2026
Same author

Mineralocorticoid and glucocorticoid receptor cooperation drives advanced phenotypes in triple-negative breast cancer.

Endocrinology·2026
Same author

Propionate metabolism is dysregulated in non-small cell lung cancer patients and EGFR-mutant drug-tolerant persister cells.

Scientific reports·2026
Same author

Correction: Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity.

eLife·2026
Same author

Propionate metabolism dysregulation promotes drug-tolerant persister cell survival in non-small cell lung cancer.

bioRxiv : the preprint server for biology·2025
Same author

Sweet signals for myelin: glucose sensing redirected to regeneration.

Nature metabolism·2025

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Oncology

Background:

  • Cell growth and proliferation are tightly regulated processes crucial for human health.
  • Disruptions in these processes are implicated in various human diseases.
  • The mammalian target of rapamycin (mTOR) pathway is a central regulator of cell growth and proliferation.

Purpose of the Study:

  • To review human disorders resulting from aberrant mTOR signaling.
  • To highlight the role of tumor suppressor proteins in controlling mTOR.
  • To connect dysregulated mTOR signaling to hamartoma syndromes and other diseases.

Main Methods:

  • Literature review of studies on mTOR signaling and human diseases.
  • Analysis of the role of tuberous sclerosis complex (TSC)-1/2, PTEN, and LKB1 tumor suppressors.

Related Experiment Videos

  • Examination of the link between mTOR dysregulation and benign tumor syndromes.

    • Main Results:

    • Inappropriate cellular signal transduction via mTOR underlies many human diseases.
    • Tuberous sclerosis complex (TSC)-1/2, PTEN, and LKB1 proteins are key regulators of mTOR.
    • Loss of these tumor suppressors results in heightened mTOR signaling and hamartoma syndromes.

    Conclusions:

    • Dysregulation of mTOR signaling is a significant factor in human disease pathogenesis.
    • Understanding mTOR regulation is critical for addressing hamartoma syndromes and related disorders.
    • Targeting mTOR signaling pathways may offer therapeutic strategies for these conditions.